首页> 外国专利> lymphocyte expansion composition; method of preparing a population of clinically relevant lymphocytes; immunotherapy for treating or preventing an infectious disease, a cancerous disease, or an autoimmune disease in a mammal; composition for use; kit for use in immunotherapy, in particular for the treatment of a cancerous disease; clinically relevant lymphocyte obtained by a method; and clinically relevant lymphocyte population obtained by a method

lymphocyte expansion composition; method of preparing a population of clinically relevant lymphocytes; immunotherapy for treating or preventing an infectious disease, a cancerous disease, or an autoimmune disease in a mammal; composition for use; kit for use in immunotherapy, in particular for the treatment of a cancerous disease; clinically relevant lymphocyte obtained by a method; and clinically relevant lymphocyte population obtained by a method

机译:淋巴细胞扩张成分;制备临床上相关的淋巴细胞群的方法;用于治疗或预防哺乳动物的感染性疾病,癌性疾病或自身免疫性疾病的免疫疗法;使用组合物;用于免疫疗法,特别是用于治疗癌症的试剂盒;通过方法获得的临床相关淋巴细胞;方法获得的与临床相关的淋巴细胞群

摘要

The present invention relates to a lymphocyte expansion composition comprising at least two types of cytokines selected from interleukin 2 (il-2), interleukin 15 (il-15) and interleukin 21 (il-21). further relates to a method of preparing a clinically relevant lymphocyte population, comprising the steps of: obtaining a body sample from a mammal, in particular a tissue sample or body fluid sample, comprising at least one lymphocyte and optionally separating cells in the body sample, in vitro body sample culture to expand and / or stimulate lymphocytes in the sample wherein the culture comprises the use of il-2, il-15 and / or il-21, and optionally determining the presence of clinically relevant lymphocyte in the cultured sample. The present invention also relates to immunotherapy and the clinically relevant lymphocyte population.
机译:本发明涉及一种淋巴细胞扩增组合物,其包含选自白介素2(IL-2),白介素15(IL-15)和白介素21(IL-21)的至少两种类型的细胞因子。进一步涉及制备临床上相关的淋巴细胞群的方法,该方法包括以下步骤:从哺乳动物获得身体样品,特别是组织样品或体液样品,其包括至少一个淋巴细胞,以及任选地分离所述身体样品中的细胞,体外身体样品培养以扩增和/或刺激样品中的淋巴细胞,其中培养物包括使用il-2,il-15和/或il-21,并任选地确定培养样品中临床相关淋巴细胞的存在。本发明还涉及免疫疗法和临床上相关的淋巴细胞群。

著录项

  • 公开/公告号BR112016028996A2

    专利类型

  • 公开/公告日2018-01-30

    原文格式PDF

  • 申请/专利权人 POLYBIOCEPT AB;

    申请/专利号BR20161128996

  • 发明设计人 MARKUS MAEURER;

    申请日2015-06-11

  • 分类号A61K35/14;A61K35/26;A61K38/20;A61K38/21;A61K39;A61P31;A61P35;A61P37;C12N5/07;G01N33/50;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号